Annual EBITDA
-$24.70 M
-$4.56 M-22.63%
01 December 2023
Summary:
Actuate Therapeutics annual earnings before interest, taxes, depreciation & amortization is currently -$24.70 million, with the most recent change of -$4.56 million (-22.63%) on 01 December 2023.ACTU EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$5.97 M
+$599.60 K+9.13%
01 September 2024
Summary:
Actuate Therapeutics quarterly earnings before interest, taxes, depreciation & amortization is currently -$5.97 million, with the most recent change of +$599.60 thousand (+9.13%) on 01 September 2024. Over the past year, it has increased by +$365.40 thousand (+5.77%).ACTU Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$28.43 M
+$365.40 K+1.27%
01 September 2024
Summary:
Actuate Therapeutics TTM earnings before interest, taxes, depreciation & amortization is currently -$28.43 million, with the most recent change of +$365.40 thousand (+1.27%) on 01 September 2024. Over the past year, it has dropped by -$11.34 million (-66.33%).ACTU TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACTU EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.6% | +5.8% | -66.3% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ACTU EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +22.6% | +13.8% | +442.4% |
Actuate Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.97 M(-9.1%) | -$28.43 M(-1.3%) |
| June 2024 | - | -$6.57 M(-20.8%) | -$28.80 M(+3.8%) |
| Mar 2024 | - | -$8.29 M(+9.0%) | -$27.75 M(+12.3%) |
| Dec 2023 | -$24.70 M | -$7.61 M(+20.1%) | -$24.70 M(+44.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$6.33 M(+14.7%) | -$17.09 M(+58.9%) |
| June 2023 | - | -$5.52 M(+5.3%) | -$10.76 M(+105.3%) |
| Mar 2023 | - | -$5.24 M | -$5.24 M |
| Dec 2022 | -$20.14 M | - | - |
FAQ
- What is Actuate Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Actuate Therapeutics?
- What is Actuate Therapeutics annual EBITDA year-on-year change?
- What is Actuate Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Actuate Therapeutics?
- What is Actuate Therapeutics quarterly EBITDA year-on-year change?
- What is Actuate Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Actuate Therapeutics?
- What is Actuate Therapeutics TTM EBITDA year-on-year change?
What is Actuate Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ACTU is -$24.70 M
What is the all time high annual EBITDA for Actuate Therapeutics?
Actuate Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$20.14 M
What is Actuate Therapeutics annual EBITDA year-on-year change?
Over the past year, ACTU annual earnings before interest, taxes, depreciation & amortization has changed by -$4.56 M (-22.63%)
What is Actuate Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ACTU is -$5.97 M
What is the all time high quarterly EBITDA for Actuate Therapeutics?
Actuate Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$5.24 M
What is Actuate Therapeutics quarterly EBITDA year-on-year change?
Over the past year, ACTU quarterly earnings before interest, taxes, depreciation & amortization has changed by +$365.40 K (+5.77%)
What is Actuate Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ACTU is -$28.43 M
What is the all time high TTM EBITDA for Actuate Therapeutics?
Actuate Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$5.24 M
What is Actuate Therapeutics TTM EBITDA year-on-year change?
Over the past year, ACTU TTM earnings before interest, taxes, depreciation & amortization has changed by -$11.34 M (-66.33%)